VALIANCE Jan founded Valiance in 2008. He brings over 20 years’ experience in growth investing. He leads the Investment Committee for the Valiance funds and is responsible for all aspects of the funds’ investment process. Jan is a Director of several Valiance entities and funds, as well as a Director of Myoscience, MDxHealth, JenaValve, 4Tech and MyCartis.
From 2003 to 2007 Jan was CEO of La Fayette Investment Management, a leading fund of hedge funds. During his tenure, the AUM of the La Fayette Funds increased from $750 million to $5.5 billion. Prior to La Fayette, from 2001 to 2003, Jan was responsible for the Permal Group’s European-based investment management and research activities. From 1995 to 2001 he was active at Lazard in Corporate Finance M&A, where he advised on transactions with a total value in excess of $40 billion.
Jan holds a BA in Business Economics from the Economics University in Gent, Belgium, and a Masters in Banking & Finance from the University of Aix-Marseille.
